Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Please share Science & Enterprise

Off-the-Shelf Stem Cell Company Forms, Gains $72M

Drop of blood

A new enterprise developing packaged blood-forming stem cells as therapies for a range of diseases began operations and raised $72 million in venture funds. . . . → Read More: Off-the-Shelf Stem Cell Company Forms, Gains $72M

Gene Therapy Delivery Company Gains $26M in Early Funds

DNA puzzle

A developer of delivery methods for gene therapies promising greater safety for patients is raising $26 million in its first venture funding round. . . . → Read More: Gene Therapy Delivery Company Gains $26M in Early Funds

Trial Underway Testing Cancer Drug as Covid-19 Therapy

SARS-CoV-2 and cell

A clinical trial enrolled and dosed its first participant testing an oral drug, initially designed to treat cancer, as a therapy for mild Covid-19 infections. . . . → Read More: Trial Underway Testing Cancer Drug as Covid-19 Therapy

Animal Genome Biotech Raises $9M in Seed Funds

Brown bear

A company discovering new drugs for a range of diseases based on the genomes of hibernating animals is raising $9 million in seed funds. . . . → Read More: Animal Genome Biotech Raises $9M in Seed Funds

Delivery Tech Licensed for CBD Epilepsy Nasal Spray

Blooming cannibis plant

A company is developing a nasal spray for epilepsy symptoms with a cannabis extract delivered in nanoscale polymer particles to the brain. . . . → Read More: Delivery Tech Licensed for CBD Epilepsy Nasal Spray

Neuroscience Software Company Raises $23M in Early Funds

Brain circuits illustration

A company developing neuroscience data collection and analytics tools for clinicians and researchers raised $22.8 million in its first venture round. . . . → Read More: Neuroscience Software Company Raises $23M in Early Funds

FDA Okays One-Time HIV Treatment Clinical Trial

HIV released from cell

A company developing a one-time treatment for HIV infections using the gene-editing technique Crispr says it received FDA clearance to begin a clinical trial. . . . → Read More: FDA Okays One-Time HIV Treatment Clinical Trial

Trial Shows VR Training Helps Correct Lazy Eye in Kids

Child with VR headset

Clinical trial findings show a digital therapy using virtual reality headsets improves vision in children with amblyopia, or lazy eye, more than corrective lenses alone. . . . → Read More: Trial Shows VR Training Helps Correct Lazy Eye in Kids

Gene-Edited Treatments in Works for Safer Cancer Therapies

T-cells and cancer cells

A cancer center and biotechnology enterprise are developing gene-edited therapies working in the gut to reduce adverse effects from cancer immunotherapies. . . . → Read More: Gene-Edited Treatments in Works for Safer Cancer Therapies

Digital Biofeedback Device Shown to Reduce PTSD

Road-side bomb

Results from a clinical trial show an electronic device reporting carbon dioxide content in breath helps people with PTSD reduce symptoms of the disorder. . . . → Read More: Digital Biofeedback Device Shown to Reduce PTSD